At iCAD, we embrace evolution it inspires us to create world-class, leading-edge technologies that empower clinicians and enhance patient care. In recent years, cancer detection and treatment has advanced significantly.
Read More: AiThority Interview with Gadi Shamia, Co-founder and CEO at Replicant From your vantage point, what have been the most impressive and important changes in your industry, and how has it changed the way you work?
#Icad medical skin#
– Xoft Axxent Electronic Brachytherapy System, which is FDA-cleared, CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body, including early-stage breast cancer, non-melanoma skin cancers (NMSC) and gynecological cancers.
#Icad medical software#
– ProFound AI, the first software for 3D mammography using AI to be FDA-cleared, and ICAD’s solutions offer benefits to clinicians and patients alike, including: Know Me Hi Michael, please tell us your role and the team you handle at iCAD.Īs the CEO of iCAD, a global Medical Technology leader providing innovative Cancer detection and therapy solutions, I have the privilege of leading a very talented team of Technology and Healthcare experts. Through passionate ingenuity, the team at iCAD delivers transformative innovations to precisely and effectively predict, detect, and treat cancer earlier, empowering clinicians to provide quality, cost-effective patient care.
0 kommentar(er)
